这三种YTHDF对应物和VIRMA是在m6A核心基因中强有力的交叉原型瘤驱动候选者
Eliana Destefanis1, Denise Sighel1, Davide Dalfovo2
1Laboratory of Translational Genomics, Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Trento 38123, Italy.
NAR cancer
|October 16, 2024
概括
N6-Methyladenosine (m6A) 修改影响癌症,但基因变异显示出相互矛盾的作用. 非酶的YTHDF和VIRMA因子经常发生变化,预测患者的存活率,是癌症的优先目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- N6-甲基氨酸 (m6A) 是最常见的内部mRNA修饰.
- m6A在癌症中的作用是重要的,但复杂的,关于m6A机械蛋白的报道是相互矛盾的.
- 对m6A因子的失调可以促进或抑制瘤的发展.
研究的目的:
- 在31种瘤类型中对15个m6A核心因子进行泛癌研究.
- 确定m6A因子改变中的跨瘤模式及其临床意义.
- 确定最有希望的m6A相关基因用于癌症研究和治疗向.
主要方法:
- 利用了来自近1万个癌症样本的癌症基因组图谱 (TCGA) 数据.
- 分析了15个核心m6A机械蛋白的副本数变异 (CNVs) 和基因表达.
- 与瘤类型和无进展生存期 (PFS) 相关的m6A因子变化.
主要成果:
- 改变基因表达,主要是通过染色体臂水平的CNVs,是m6A因子最常见的失调模式.
- YTHDF1,YTHDF2,YTHDF3和VIRMA是最常发生变化的因素.
- 与METTL3.3不同的是,YTHDF和VIRMA基因对PFS表现出一致的泛癌预测能力.
结论:
- 非酶的m6A因子,特别是YTHDF和VIRMA,在癌症中经常发生变化,并预测患者的生存率.
- 与METTL3.3等酶因子相比,这些基因对m6A在癌症中的作用提供了更一致的见解.
- YTHDF和VIRMA是剖析m6A功能和开发新型癌症疗法的优先目标.
相关概念视频
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
Mechanisms of Retrovirus-induced Cancers
5.0K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.0K
Non-LTR Retrotransposons
11.4K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.4K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
LTR Retrotransposons
17.4K
LTR retrotransposons are class I transposable elements with long terminal repeats flanking an internal coding region. These elements are less abundant in mammals compared to other class I transposable elements. About 8 percent of human genomic DNA comprises LTR retrotransposons. Some of the common examples of LTR retrotransposons are Ty elements in yeast and Copia elements in Drosophila.
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...
17.4K


